Differences in methylation profiles between long-term survivors and short-term survivors of IDH- wildtype glioblastoma

Abstract Background Patients with glioblastoma (GBM) have a median overall survival (OS) of approximately 16 months. However, approximately 5% of patients survive >5 years. This study examines the differences in methylation profiles between long-term survivors (>5 years, LTS) a...

Бүрэн тодорхойлолт

-д хадгалсан:
Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Matthijs van der Meulen, Ronald Ramos, Mathew Voisin, Vikas Patil, Qingxia Wei, Olivia Singh, Seth Climans, Navya Kalidindi, Rosemarylin Or, Ken Aldape, Phedias Diamandis, David G. Muñoz, Gelareh Zadeh, Warren Mason
Формат: Artigo
Хэл сонгох:англи
Хэвлэсэн: 2024
Онлайн хандалт:https://doi.org/10.1093/noajnl/vdae001
https://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdae001/55536889/vdae001.pdf
Шошгууд: Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!